The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study

Background: Genitourinary syndrome of menopause (GSM) majorly caused by the physiological decline in estrogen, affects up to 90% of menopausal women. Hormonal therapy seems to be an effective treatment, often not executable for contraindication or patient’s low compliance to local or systemic medica...

Full description

Bibliographic Details
Main Authors: Violante Di Donato, Ottavia D'Oria, Andrea Giannini, Maria Scudo, Carmel Sher, Margherita Fischetti, Giorgia Perniola, Innocenza Palaia, Marco Monti, Ludovico Muzii, Pierluigi Benedetti Panici
Format: Article
Language:English
Published: IMR Press 2022-09-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909212
_version_ 1828228268766003200
author Violante Di Donato
Ottavia D'Oria
Andrea Giannini
Maria Scudo
Carmel Sher
Margherita Fischetti
Giorgia Perniola
Innocenza Palaia
Marco Monti
Ludovico Muzii
Pierluigi Benedetti Panici
author_facet Violante Di Donato
Ottavia D'Oria
Andrea Giannini
Maria Scudo
Carmel Sher
Margherita Fischetti
Giorgia Perniola
Innocenza Palaia
Marco Monti
Ludovico Muzii
Pierluigi Benedetti Panici
author_sort Violante Di Donato
collection DOAJ
description Background: Genitourinary syndrome of menopause (GSM) majorly caused by the physiological decline in estrogen, affects up to 90% of menopausal women. Hormonal therapy seems to be an effective treatment, often not executable for contraindication or patient’s low compliance to local or systemic medical therapy. Fractional CO2 laser therapy is an emerging and effective choice for women affected by vulvo-vaginal atrophy (VVA), promoting collagen regeneration and improving blood flow of the vaginal mucosa and elasticity of tissues. Methods: Ninety-two menopausal Patients affected by vulvo-vaginal atrophy (VVA) were considered for the present prospective observational study. All women were treated with Fractional CO2 laser Lumenis AcuPulse in a fractionated sequential mode laser pulse. Patients were requested to complete questionnaires regarding the Female Sexual Functional Index (FSFI), Female Sexual Distress Scale (FSDS) and severity of Most Bothersome Symptoms (MBS) at baseline (T0) and at three-month following three-treatment-sessions (T1). Results: Data indicated a significant improvement of MBS (vaginal itching (p < 0.0001), post-coital vaginal bleeding (p < 0.002), vaginal dryness (p < 0.0001), dyspareunia (p < 0.0001) and dysuria (p < 0.0001), higher Vaginal Health Index Score (VHIS) (4.1 ± 1.21; 95% CI = 3.84–4.35) and reduces pH (–0.53 ± 0.24; 95% CI = 0.48–0.58) after CO2 laser treatment. A significantly improvement of FSFI Total score (p < 0.0001) and FSDS (p < 0.0001) have been demonstrated. Conclusions: Fractional CO2 laser improves vaginal health as well as signs and symptoms associated with GSM, while significantly elevating quality of life and sexual functionality among postmenopausal symptomatic women.
first_indexed 2024-04-12T18:18:39Z
format Article
id doaj.art-350648107b3d475f954a99026ddfe039
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-04-12T18:18:39Z
publishDate 2022-09-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-350648107b3d475f954a99026ddfe0392022-12-22T03:21:31ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632022-09-0149921210.31083/j.ceog4909212S0390-6663(22)01889-9The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational StudyViolante Di Donato0Ottavia D'Oria1Andrea Giannini2Maria Scudo3Carmel Sher4Margherita Fischetti5Giorgia Perniola6Innocenza Palaia7Marco Monti8Ludovico Muzii9Pierluigi Benedetti Panici10Department of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Medical and Surgical Sciences and Translational Medicine, PhD Course in “Translational Medicine and Oncology'', Sapienza University, 00185 Rome, ItalyDepartment of Medical and Surgical Sciences and Translational Medicine, PhD Course in “Translational Medicine and Oncology'', Sapienza University, 00185 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyDepartment of Maternal and Child Health and Urological Sciences, Sapienza University, Umberto I Hospital, 00161 Rome, ItalyBackground: Genitourinary syndrome of menopause (GSM) majorly caused by the physiological decline in estrogen, affects up to 90% of menopausal women. Hormonal therapy seems to be an effective treatment, often not executable for contraindication or patient’s low compliance to local or systemic medical therapy. Fractional CO2 laser therapy is an emerging and effective choice for women affected by vulvo-vaginal atrophy (VVA), promoting collagen regeneration and improving blood flow of the vaginal mucosa and elasticity of tissues. Methods: Ninety-two menopausal Patients affected by vulvo-vaginal atrophy (VVA) were considered for the present prospective observational study. All women were treated with Fractional CO2 laser Lumenis AcuPulse in a fractionated sequential mode laser pulse. Patients were requested to complete questionnaires regarding the Female Sexual Functional Index (FSFI), Female Sexual Distress Scale (FSDS) and severity of Most Bothersome Symptoms (MBS) at baseline (T0) and at three-month following three-treatment-sessions (T1). Results: Data indicated a significant improvement of MBS (vaginal itching (p < 0.0001), post-coital vaginal bleeding (p < 0.002), vaginal dryness (p < 0.0001), dyspareunia (p < 0.0001) and dysuria (p < 0.0001), higher Vaginal Health Index Score (VHIS) (4.1 ± 1.21; 95% CI = 3.84–4.35) and reduces pH (–0.53 ± 0.24; 95% CI = 0.48–0.58) after CO2 laser treatment. A significantly improvement of FSFI Total score (p < 0.0001) and FSDS (p < 0.0001) have been demonstrated. Conclusions: Fractional CO2 laser improves vaginal health as well as signs and symptoms associated with GSM, while significantly elevating quality of life and sexual functionality among postmenopausal symptomatic women.https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909212vulvovaginal atrophyfractional co2 lasermenopauselaser safetygenitourinary syndrome
spellingShingle Violante Di Donato
Ottavia D'Oria
Andrea Giannini
Maria Scudo
Carmel Sher
Margherita Fischetti
Giorgia Perniola
Innocenza Palaia
Marco Monti
Ludovico Muzii
Pierluigi Benedetti Panici
The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
Clinical and Experimental Obstetrics & Gynecology
vulvovaginal atrophy
fractional co2 laser
menopause
laser safety
genitourinary syndrome
title The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
title_full The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
title_fullStr The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
title_full_unstemmed The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
title_short The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study
title_sort efficacy of fractional co2 laser in the treatment of genitourinary syndrome of menopause a large prospective observational study
topic vulvovaginal atrophy
fractional co2 laser
menopause
laser safety
genitourinary syndrome
url https://www.imrpress.com/journal/CEOG/49/9/10.31083/j.ceog4909212
work_keys_str_mv AT violantedidonato theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT ottaviadoria theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT andreagiannini theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT mariascudo theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT carmelsher theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT margheritafischetti theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT giorgiaperniola theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT innocenzapalaia theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT marcomonti theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT ludovicomuzii theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT pierluigibenedettipanici theefficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT violantedidonato efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT ottaviadoria efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT andreagiannini efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT mariascudo efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT carmelsher efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT margheritafischetti efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT giorgiaperniola efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT innocenzapalaia efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT marcomonti efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT ludovicomuzii efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy
AT pierluigibenedettipanici efficacyoffractionalco2laserinthetreatmentofgenitourinarysyndromeofmenopausealargeprospectiveobservationalstudy